Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Articles published by OptimizeRx Corporation

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Second Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports First Quarter 2024 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX WMT
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
From OptimizeRx Corporation
Via GlobeNewswire
Tickers AWH OPRX
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Third Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Expands AI Powered Omnichannel Platform
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Reports Second Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
From OptimizeRx Corporation
Via GlobeNewswire
Tickers OPRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.